Turning the Tide on Hospital-Acquired Sepsis with AI
Device manufacturers that unravel technical and regulatory issues will lead the fight.
Article featured in CLP by Rob Morgan, PhD, Paulo Pinheiro, PhD, and Andrew Chapman, MBA
Hospital-acquired infections, also known as healthcare-associated infections (HAIs), are a major burden for global healthcare. In the United Kingdom, they represent an annual cost of around £1billion to the National Health Service.1 And in the United States, the Centers for Disease Control and Prevention estimates that HAIs account for 1.7 million infections and 99,000 associated deaths each year.2
HAIs can include a number of conditions, such as hospital-acquired pneumonia, catheter-associated urinary tract infections, and surgical site infections, which may develop in patients who have undergone invasive treatments or procedures involving devices, surgical equipment, or monitoring technologies. The same equipment that has revolutionized healthcare—improving patient outcomes and saving lives—can sometimes result in life-threatening aftereffects. Inadequate cleaning, maintenance, or design of this equipment can have fatal consequences.
To read the full article, please follow this link to CLP.